
Results for First Quarter ended August 31, 2025
A link to the PDF version of the financial statements is available here: http://www.rns-pdf.londonstockexchange.com/rns/6451E_2-2025-10-23.pdf
A link to the PDF version of the MD&A is available here: http://www.rns-pdf.londonstockexchange.com/rns/6451E_1-2025-10-23.pdf
HIGHLIGHTS
Highlights for the three months ended
Operational
· In
Earlier stage exploration continues at the
· In
· In
Financial
· On
· Post period end, on
Outlook and Strategy
The Company will focus its investment in
In
In
|
Condensed Interim Consolidated Statements of Financial Position |
|
|
|
(Expressed in thousands of |
|
|
|
Unaudited |
|
|
|
|
As at $ |
As at $ |
|
ASSETS |
|
|
|
Current assets |
|
|
|
Cash |
3,906 |
4,877 |
|
Restricted cash |
12 |
12 |
|
Accounts receivable and other assets |
435 |
434 |
|
Assets of |
11 |
20 |
|
Total current assets |
4,364 |
5,343 |
|
Non-current assets |
|
|
|
Property and equipment |
283 |
288 |
|
Exploration and evaluation assets |
4,632 |
3,858 |
|
Total assets |
9,279 |
9,489 |
|
LIABILITIES AND EQUITY |
|
|
|
Current liabilities |
|
|
|
Accounts payable and accrued liabilities |
545 |
623 |
|
Warrant liability |
1,785 |
1,706 |
|
Liabilities of |
564 |
529 |
|
Total current liabilities |
2,894 |
2,858 |
|
|
|
|
|
Total liabilities |
2,894 |
2,858 |
|
Deficit |
|
|
|
Share capital |
74,901 |
74,675 |
|
Share-based payments reserve |
11,004 |
10,931 |
|
Warrants |
384 |
436 |
|
Currency translation reserve |
(1,934) |
(2,159) |
|
Accumulated deficit |
(77,976) |
(77,258) |
|
Total equity attributable to owners of the parent |
6,379 |
6,625 |
|
Non-controlling interest |
6 |
6 |
|
Total equity |
6,385 |
6,631 |
|
Total liabilities and equity |
9,279 |
9,489 |
|
Condensed Interim Consolidated Statements of Loss and Comprehensive Loss |
||
|
(Expressed in thousands of |
|
|
|
(Except common shares and per share amounts) |
|
|
|
Unaudited |
|
|
|
|
Three Months Ended $ |
Three Months Ended $ |
|
|
|
|
|
|
|
|
|
Corporate and administrative expenses |
(398) |
(435) |
|
Exploration expenses |
(61) |
(76) |
|
Share-based compensation |
(73) |
- |
|
Other income |
4 |
38 |
|
Net finance cost |
(4) |
(3) |
|
Loss on fair value of warrants |
(79) |
- |
|
Foreign exchange (loss) gain |
(74) |
28 |
|
Net loss for the period for continuing operations |
(685) |
(448) |
|
(Loss) income from discontinued operations |
(33) |
169 |
|
Net loss for the period |
(718) |
(279) |
|
Item which may be subsequently reclassified to profit or loss: |
|
|
|
Cumulative translation adjustment |
225 |
(388) |
|
Total comprehensive loss for the period |
(493) |
(667) |
|
|
|
|
|
Basic and diluted net (loss) income per share for |
|
|
|
- continuing operations |
(0.00) |
(0.00) |
|
- discontinued operations |
(0.00) |
0.00 |
|
Weighted average number of common shares outstanding |
314,235,630 |
193,211,503 |
|
Condensed Interim Consolidated Statements of Cash Flows |
||
|
(Expressed in thousands of |
|
|
|
Unaudited |
Three Months Ended $ |
Three Months Ended $ |
|
|
|
|
|
Operating activities |
|
|
|
Net loss for the period for continued and discontinued operations |
(718) |
(279) |
|
Adjustments for |
|
|
|
Depreciation |
5 |
5 |
|
Share-based compensation |
73 |
- |
|
Loss on fair value of warrants |
79 |
- |
|
Foreign exchange and other |
(6) |
(47) |
|
Changes in non-cash working capital items: |
|
|
|
Accounts receivable and other assets |
(1) |
(10) |
|
Accounts payable and accrued liabilities |
(32) |
(215) |
|
Net cash used in operating activities |
(600) |
(546) |
|
|
|
|
|
Investing activities |
|
|
|
Exploration and evaluation expenditures |
(554) |
(85) |
|
Net cash used in provided by investing activities |
(554) |
(85) |
|
|
|
|
|
Financing activities |
|
|
|
Proceeds from exercise of warrants |
174 |
- |
|
Net cash provided by financing activities |
174 |
- |
|
Net change in cash |
(980) |
(631) |
|
Net change in cash classified within assets discontinued operations |
9 |
13 |
|
Cash, beginning of period |
4,877 |
1,328 |
|
Cash end of period |
3,906 |
710 |
|
|
|
|
|
Operating activities |
|
|
|
- continuing operations |
(600) |
(533) |
|
- discontinued operations |
- |
(13) |
|
Investing activities |
|
|
|
- continuing operations |
(554) |
(85) |
|
Financing activities |
|
|
|
- continuing operations |
183 |
- |
|
- discontinued operations |
(9) |
- |
For further information, visit www.orosur.ca, follow on X @orosurm or please contact:
Tel: +1 (778) 373-0100
Tel: +44 (0) 20 3 470 0470
Tel: +44 (0)20 3657 0050
orosur@flagstaffcomms.com Tel: +44 (0)207 129 1474
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into
Neither
About
Qualified Persons Statement
The information in this news release was compiled, reviewed, verified and approved by Mr. Brad George, BSc Hons (Geology and Geophysics), MBA, Member of the
Industry standard QAQC protocols are put in place with approximately 10% of total submitted samples being blanks, repeats or Certified Reference Materials (CRMs). Samples for holes PEP-001 to PEP-011 were sent to the
Samples from PEP-012 onwards are sent to
30 gram nominal weight samples are then subject to fire assay and AAS analysis for gold with gravimetric re-finish for overlimit assays of >5 g/t. ICP-MS Ultra-Trace level multi-element four-acid digest analyses may also undertaken for such elements as silver, copper, lead and zinc, etc.
Gold intersections are reported using a lower cut-off of 0.3g/t Au over 3m. Intersections are quoted as downhole thicknesses. True thicknesses are unknown.
Forward Looking Statements
All statements, other than statements of historical fact, contained in this news release constitute "forward looking statements" within the meaning of applicable securities laws, including but not limited to the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and are based on expectations estimates and projections as of the date of this news release.
Forward-looking statements include, without limitation, the continuing focus on the Pepas prospect, the exploration plans in
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the